In July 2025, CorTec achieved a historic milestone with the first-ever human implantation of a fully implantable, German-developed Brain-Computer Interface system, performed at Harborview Medical Center in Seattle. As part of an FDA-approved trial led by researchers from the University of Washington and UCLA, the study targets motor recovery in stroke patients and marks a major step forward in neurorehabilitation.
